Does DACOMITINIB Cause Hepatic function abnormal? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hepatic function abnormal have been filed in association with DACOMITINIB (Vizimpro). This represents 0.9% of all adverse event reports for DACOMITINIB.
6
Reports of Hepatic function abnormal with DACOMITINIB
0.9%
of all DACOMITINIB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Hepatic function abnormal From DACOMITINIB?
Of the 6 reports, 1 (16.7%) resulted in death, 4 (66.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACOMITINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DACOMITINIB Cause?
Death (253)
Diarrhoea (114)
Rash (108)
Neoplasm progression (78)
Paronychia (55)
Blood pressure increased (47)
Off label use (35)
Pruritus (34)
Dyspnoea (30)
Carcinoembryonic antigen increased (28)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which DACOMITINIB Alternatives Have Lower Hepatic function abnormal Risk?
DACOMITINIB vs DACTINOMYCIN
DACOMITINIB vs DALBAVANCIN
DACOMITINIB vs DALFAMPRIDINE
DACOMITINIB vs DALTEPARIN
DACOMITINIB vs DAMOCTOCOG ALFA PEGOL